Difference between revisions of "Eluvixtamab (AMG-330)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "Category:Antibody medications" to "")
Tags: mobile edit mobile web edit
Line 4: Line 4:
 
[[Category:Drugs]]
 
[[Category:Drugs]]
  
[[Category:Immunotherapeutic]]
+
[[Category:Intravenous medications]]
  
  

Revision as of 01:18, 29 February 2020

Mechanism of action

Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3